Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-GO in Relapsed/Refractory Indolent Lymphoma
NCT00954005Phase 2Terminated
- Sponsor
- German Low-Grade Lymphoma Study Group
- Start
- Jan 2003
- Primary completion
- Jun 2011
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in lymphoma, sponsored by German Low-Grade Lymphoma Study Group. Started Jan 2003; status: terminated.
02
Drugs
oxaliplatin
03
Conditions
lymphoma
Beyond the preview
Go deeper on NCT00954005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00954005.